PepJunkie Home of the Peptonauts
More
HomeThe PulseAtlasDiscussHunter-GathererResearchProfileSearch

Research

Potassium phosphate (injectable) — living evidence map

The Atlas page holds the claims; this is how its evidence evolved.

Summary

In a randomized study in critically ill patients with hypophosphatemia, 30 or 45 mmol of intravenous potassium phosphate corrected phosphate by the end of the infusion in 98%, whether given over 2 or 4 hours (moderate) or 3 or 6 hours (severe), with no adverse events. · pmid:12845429

Identity

PubChem CID 24450: Potassium Phosphate, Dibasic, HK2O4P, 174.176 g/mol. · pubchem:24450

CAS registry number 7758-11-4. · pubchem:24450

IUPAC name: dipotassium;hydrogen phosphate. · pubchem:24450

Where the evidence actually sits

Emerging100%

Proportion of the 1 claim about Potassium phosphate (injectable) standing at each tier. Community volume is shown on the Consensus tab beside this and is never averaged into it.

Living evidence history

Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia. (2003) · emerging20032003

1 resolved citation, oldest to newest, coloured by tier. Retractions and contradictions land here as they are recorded.

Structure

No structure representation on record. PepJunkie draws only what an authoritative record supplies; for a peptide that is the residue sequence, and none has been curated for Potassium phosphate (injectable) yet.

Dose evidence, rung by rung

No established safe human dose. Nothing on file establishes one. That is a statement about the evidence PepJunkie holds, not a promise about the molecule.

  1. Approved-label dose · a resolved regulatory document names a labelled dose

    nothing resolved on this rung

  2. Studied human doses · resolved human studies at the established tier

    nothing resolved on this rung

  3. Observational evidence · resolved human data at the emerging tier: thin, or contested
    • Intravenous phosphate in the intensive care unit: more aggressive repletion regimens for moderate and severe hypophosphatemia. · pmid 12845429 · 2003
  4. Community-reported protocols · protocol propositions from distinct members, counted once per human

    nothing resolved on this rung

  5. Preclinical evidence · resolved animal, cell or mechanistic work

    nothing resolved on this rung

1 resolved citation, 0 unresolved (an unresolved citation lends nothing). Community volume is its own rung and is never averaged into the evidence rungs.